Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lannett to acquire UCB’s Kremers Urban Pharmaceuticals Unit for $1.23 Billion
Thursday, September 03, 2015Lannett Company Inc has agreed to buy UCB SA s Kremers Urban Pharmaceuticals Inc for billion The deal with tax benefits expected to top million also calls for potential contingency payments under sales and timing thresholds Lannett said it expects...
Valeant Pharmaceuticals agrees to acquire Synergetics USA
Thursday, September 03, 2015Valeant Pharmaceuticals International Inc agreed to acquire precision surgical devices supplier Synergetics USA Inc for at least million in a deal that aims to boost Bausch Lombs global presence in vitreoretinal surgery Shares of Missouribased Syn...
Novartis launches Neupogen copycat Zarxio in U.S. market
Thursday, September 03, 2015Novartis AG has launched the first biosimilar drug in the United States after a US appeals court declined on Wednesday to stop the sale of the companys copycat version of Amgen Incs blockbuster cancer drug Neupogen Novartis unit Sandoz said on Thurs...
Alexion gets EU approval for drug acquired in Synageva deal
Wednesday, September 02, 2015Ten weeks after closing its billion purchase of Synageva BioPharma Corp Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal an enzymereplacement therapy for an ultrarare life threatening dise...
Valeant Strikes Psoriasis-Drug Pact with AstraZeneca
Wednesday, September 02, 2015Canadas Valeant Pharmaceuticals International Inc has struck a deal with AstraZeneca PLC for the rights to sell psoriasis treatment brodalumab after Amgen Inc dropped its own collaboration with the UKbased drug maker over concerns about the drugs sid...
Bristol-Myers Granted Right to Buy Promedior for up to $1.25 Billion
Tuesday, September 01, 2015BristolMyers Squibb Co said Monday that it has been granted the exclusive right to buy privately held Promedior Inc and its experimental fibrosis treatment for up to billion Under the terms of the agreement BristolMyers will pay million in cash up...
Google, Sanofi Join Forces on Diabetes Monitoring and Treatment
Tuesday, September 01, 2015Google Inc said Monday its healthcare research unit agreed to work with European pharmaceutical company Sanofi SA on new ways to monitor and treat diabetes The companies declined to say how much they are investing in the partnership Sanofi is a lea...
Strides Arcolab completes acquisition of Aspen's generic business in Australia
Tuesday, September 01, 2015Pharmaceuticals firm Strides Arcolab today said it has completed the Rs crore acquisition of Aspen Pharmacares generic pharmaceutical business and related assets in Australia The transaction has now achieved closure on completion of closing conditio...
Sun Pharma completes opiates business acquisition in Australia
Tuesday, September 01, 2015Sun Pharmaceuticals has completed the acquisition of GSKs opiates manufacturing facilities in Australia The acquisition was announced in March Opiates which comprise of narcotics raw materials are classified as controlled substances and are used to...
Bayer heart failure drug cuts deaths in mid-stage trial
Tuesday, September 01, 2015Bayer will move a heart failure drug into finalstage testing this year boosting its ambitions in cardiovascular treatments after the experimental medicine showed a striking reduction in deaths in a midstage trial Having done well with recently launc...
